On June 1, 2020, the USTR Office issued the uniform rules which are the last hurdle before the implementation of the agreement on July 1, 2020. On November 30, 2018, the USMCA was signed as planned by the three parties at the G20 summit in Buenos Aires.   Disputes over labour rights, steel and aluminum prevented ratification of this version of the agreement.   Canadian Deputy Prime Minister Chrystia Freeland, U.S. Trade Representative Robert Lightizer, and Mexican Under-Secretary of State for North America Jesus Seade officially signed a revised agreement on December 10, 2019, ratified by the three countries on March 13, 2020. The USMCA establishes the highest level of a U.S. trade agreement for strong and effective protection and enforcement of intellectual property rights. This is a significant enhancement of NAFTA. Nevertheless, in December 2019, following negotiations on the revision of the USMCA text signed in November 2018, substantial changes were made to Chapter 20 of intellectual property. National procedures for ratifying the agreement in the United States are governed by the legislation of the Trade Promotion Authority, which is also known as the fast-track authority. In summary, the USMCA contains many provisions that advance public health and FDA regulatory approaches. Now that the agreement has come into effect, we will continue to follow what it means for the FDA, for public health and for our regulated industries. On December 19, 2019, the U.S.
House of Representatives passed the USMCA with multiparty support with 385 votes (Democracy 193, Republican 192) to 41 (Democracy 38, Republican 2, Independent 1).  On January 16, 2020, the U.S. Senate passed the trade agreement by 89 votes (Democrats 38, Republicans 51) to 10 (Democracy 8, Republican 1, Independent 1) and the bill was forwarded to the White House for the signature of Donald Trump.  On January 29, 2020, Trump signed the agreement (Public Law No: 116-113).  NAFTA has been formally amended, but not the 1989 Canada-U.S. Free Trade Agreement, which is only „suspended.“  The agreed text of the agreement was signed by the heads of state and government of the three countries on 30 November 2018 as a secondary event at the 2018 G20 summit in Buenos Aires, Argentina.  The English, Spanish and French versions will also be binding and the agreement will take effect after ratification by the three states through the adoption of enabling laws.  Trade policy is a subject that does not necessarily come to mind when we think of the FDA.